This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked TUBB2A Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-TUBB2A WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~49.9 kDa | |
| Gel | 12–15% (standard starting point) | |
| Positive control | Placenta (IHC candidate; verify WB) +3 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Phosphorylated + Acetylated | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 1 isoform(s) |
The M06868 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | Target-positive lysate and matched negative control (standard starting point) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | M06868; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
TUBB2A is predicted at 49.9 kDa; listed modifications could affect migration, but no empirical band size or visible shift is demonstrated.
| Band near 49.9 kDa | Consistent with the predicted full-length TUBB2A size; confirm identity with antibody controls |
| Closely spaced doublet near 50 kDa | Modified TUBB2A is possible, but distinct migration is not established |
| Band slightly above 50 kDa | Polyglutamylation is possible, but its effect on migration is not established |
| Weak band in a soluble fraction | Cytoskeletal TUBB2A may be underrepresented in that fraction |
| Predicted molecular mass | Places full-length TUBB2A near 49.9 kDa |
| Phosphorylation at Ser40 and Ser172 | Adds modification mass, but a visible band shift is not established |
| Alternate acetylation or succinylation at Lys58 | Changes mass slightly; distinct migration is not established |
| Polyglutamylation at residue 438 | Can add variable mass; its effect on this blot is not established |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Cytoskeletal TUBB2A may be poorly recovered | Check the insoluble fraction and confirm lysis efficiency |
| Band higher than expected | A modified species is possible, but its identity is unproven | Compare with a validated TUBB2A antibody and an appropriate modification control |
| Band lower than expected | Protein breakdown or a nonspecific band is possible | Use protease inhibitors and confirm band identity with an independent antibody |
| Multiple bands | Modified species or antibody cross-reactivity may contribute | Check antibody specificity and compare treated and untreated samples |
| Weak or no signal | Cytoskeletal protein recovery or antibody detection may be insufficient | Check fraction recovery, loading, and a positive lysate control |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Placenta | endothelial cells | High | Protein (IHC) | HPA → |
| Skin | cells in granular layer | High | Protein (IHC) | HPA → |
| Testis | pachytene spermatocytes | High | Protein (IHC) | HPA → |
| Cerebral cortex | neuropil | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Appendix | glandular cells | Not detected | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Caudate | glial cells | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for TUBB2A, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
M06868 is a monoclonal anti-TUBB2A antibody listed for human, mouse, and rat. Its Western blot image shows mouse and rat brain tissue at 1:100000 dilution; no human sample is shown in the supplied evidence.
Which to pick: M06868 is the only listed option. Its Western blot image provides a practical starting point for mouse or rat brain tissue; human reactivity is listed, but the supplied image does not show a human sample.